Jane and Dan chat to Dr Rochelle Gellatly, a clinical pharmacy specialist in critical care, an Australian Advanced Practice Pharmacist in Cardiology and a Board Certified Pharmacotherapy Specialist with added qualifications in Cardiology. She is currently working in Vancouver.

We talk to Rochelle about:

• Recent changes in thinking about hyperlipidaemia, target LDLs and risk assessment
• How scores for cardiovascular risk are used in practice
• What we know (or don't) about the optimal dose of a statin and the frequency of adverse events